Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells
Pladienolide B is a potent cancer cell growth inhibitor that targets the SF3b1 subunit of the spliceosome. There is considerable interest in the compound as a tool to study SF3b1 function in cancer. However, so far little information is available on the molecular mechanism of SF3b1 eliciting apoptos...
Main Authors: | Qianjing Zhang, Cuixia Di, Junfang Yan, Fang Wang, Tao Qu, Yupei Wang, Yuhong Chen, Xuetian Zhang, Yang Liu, Hongying Yang, Hong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1596922 |
Similar Items
-
Titration of SF3B1 Activity Reveals Distinct Effects on the Transcriptome and Cell Physiology
by: Karen S. Kim Guisbert, et al.
Published: (2020-12-01) -
Total Syntheses of Pladienolide-Derived Spliceosome Modulators
by: Jaehoon Sim, et al.
Published: (2021-09-01) -
Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
by: Mari C. Vázquez-Borrego, et al.
Published: (2019-09-01) -
Therapeutic potential of CDK11 in cancer
by: Dalibor Blazek
Published: (2023-03-01) -
Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells
by: Ksenia S. Anufrieva, et al.
Published: (2018-06-01)